Sex-related Differences in Profiles and Clinical Outcomes of Inflammatory Bowel Disease: a Systematic Review and Meta-analysis

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2024 Nov 23

PMID 39580396

Authors

Dana A Salem

Rawan El-Ijla

Razan R AbuMusameh

Khaled A Zakout

Alaa Y Abu Halima

Mohammed T Abudiab

Yahya M Banat

Basel F Alqeeq

Mohammed Al-Tawil

Khaled Matar

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory bowel disease (IBD) is a chronic and idiopathic condition that includes both Crohn's disease (CD) and ulcerative colitis (UC). The impact of sex on the disease course and the clinical outcomes not fully understood. Our systematic review and meta-analysis aims to explore the differences in the clinical outcomes in IBD.

Method: A systematic review and meta-analysis was done by searching in the PubMed /MEDLINE, Embase, and Scopus databases. We used the Random-Effects model to estimate risk ratios (RR) for binary outcomes and mean difference and hedges' g for continuous outcomes.

Result: A total of 44 unique studies were included. Our analysis revealed distinct sex differences in various outcomes of IBD. Anxiety was more prevalent in females (RR: 0.73; 95% CI [0.64, 0.82]) and females in the CD subgroup (RR: 0.76; 95% CI [0.62, 0.93]; p = 0.01. While depression was diagnosed more frequently in females (RR: 0.80; 95% CI [0.66, 0.97] in the total population of the study, subgroup analysis showed no sex difference. Additionally, quality of life scores were worse in females in the total population (Hedges' g: 0.24; 95% CI [0.05, 0.42]) with no significant difference in subgroup analyses. A significantly higher mortality risk was estimated in males (RR: 1.26; 95% CI [1.07, 1.48]) and in subgroup analysis for males with UC (RR: 1.48; 95% CI [1.19, 1.84]; p = 0.00) with no significant difference in CD. Regarding disease location, male patients were less likely to present with proctitis (RR: 0.67; 95% CI [0.50, 0.91]) when compared to females. Males had more frequent indications for surgery (RR: 1.10; 95% CI [1.01, 1.20]), however, no significant difference was found in subgroup analyses for CD or UC. Also, males were older at the time of admission (MD: 1.39 years; 95% CI [0.10, 2.68]). No significant sex differences were found in terms of hospitalization rates or disease behavior.

Conclusion: In conclusion, our meta-analysis shows that males face higher risks of early mortality and require more IBD surgeries, whereas females experience greater levels of anxiety and depression. These findings emphasize the need to consider sex disparities in IBD management.

Citing Articles

Association between pre-existing chronic conditions and severity of first SARS-CoV-2 infection symptoms among adults living in Canada: a population-based survey analysis from January 2020 to August 2022.

Cheta N, Zakaria D, Demers A, Abdullah P, Aziz S BMC Public Health. 2025; 25(1):981.

PMID: 40075342 PMC: 11905645. DOI: 10.1186/s12889-025-22041-7.

References

Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P, Maillard M . Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS One. 2017; 12(2):e0171864. PMC: 5302448. DOI: 10.1371/journal.pone.0171864. View

Case A, Paxson C . Sex differences in morbidity and mortality. Demography. 2005; 42(2):189-214. DOI: 10.1353/dem.2005.0011. View

Cornish J, Tan E, Simillis C, Clark S, Teare J, Tekkis P . The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008; 103(9):2394-400. DOI: 10.1111/j.1572-0241.2008.02064.x. View

Pfaffl M, Lange I, Meyer H . The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J Steroid Biochem Mol Biol. 2003; 84(2-3):159-66. DOI: 10.1016/s0960-0760(03)00025-6. View

Wagtmans M, Verspaget H, Lamers C, van Hogezand R . Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol. 2001; 96(5):1541-6. DOI: 10.1111/j.1572-0241.2001.03755.x. View

Manninen P, Karvonen A, Huhtala H, Rasmussen M, Salo M, Mustaniemi L . Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis. 2012; 6(5):524-8. DOI: 10.1016/j.crohns.2011.10.009. View

Umiker B, Andersson S, Fernandez L, Korgaokar P, Larbi A, Pilichowska M . Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. Eur J Immunol. 2014; 44(5):1503-16. PMC: 4028042. DOI: 10.1002/eji.201344283. View

Saha S, Zhao Y, Shah S, Esposti S, Lidofsky S, Shapiro J . Body image dissatisfaction in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015; 21(2):345-52. PMC: 4373552. DOI: 10.1097/MIB.0000000000000270. View

Heath E, Kim R, Wilson A . A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease. Dig Dis Sci. 2021; 67(9):4287-4294. DOI: 10.1007/s10620-021-07177-x. View

10.

Marin L, Manosa M, Garcia-Planella E, Gordillo J, Zabana Y, Cabre E . Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol. 2012; 48(6):713-20. DOI: 10.1007/s00535-012-0700-2. View

11.

Janke K, Klump B, Gregor M, Meisner C, Haeuser W . Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11(3):272-86. DOI: 10.1097/01.mib.0000160809.38611.f7. View

12.

Loftus Jr E . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. DOI: 10.1053/j.gastro.2004.01.063. View

13.

Garcia-Alanis M, Quiroz-Casian L, Castaneda-Gonzalez H, Arguelles-Castro P, Toapanta-Yanchapaxi L, Chiquete-Anaya E . Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease. Gastroenterol Hepatol. 2020; 44(3):206-213. DOI: 10.1016/j.gastrohep.2020.06.025. View

14.

Goodman W, Erkkila I, Pizarro T . Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020; 17(12):740-754. PMC: 7750031. DOI: 10.1038/s41575-020-0354-0. View

15.

De Simone V, Matteoli G . Estrogen-Mediated Effects Underlie Gender Bias in Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2018; 5(4):638-639.e1. PMC: 5924746. DOI: 10.1016/j.jcmgh.2018.01.017. View

16.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

17.

Severs M, Spekhorst L, Mangen M, Dijkstra G, Lowenberg M, Hoentjen F . Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies. Inflamm Bowel Dis. 2018; 24(6):1298-1306. DOI: 10.1093/ibd/izy004. View

18.

Browning B, Annese V, Barclay M, Bingham S, Brand S, Buning C . Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet. 2007; 45(1):36-42. DOI: 10.1136/jmg.2007.050773. View

19.

Osamura A, Suzuki Y . Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors. Dig Dis Sci. 2017; 63(1):204-208. DOI: 10.1007/s10620-017-4846-x. View

20.

Muller K, Prosser R, Bampton P, Mountifield R, Andrews J . Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2009; 16(4):657-63. DOI: 10.1002/ibd.21090. View